Skip to content
    Sherpa Healthcare Partners logo

    Sherpa Healthcare Partners

    Beijing, ChinaFounded 2018
    www.sherpahp.comLinkedIn
    HealthcareBiotech & Life Sciences

    Sherpa Healthcare Partners is a Beijing-based venture capital firm founded in 2018 that targets early- to growth-stage investments in biotech, life sciences, medical devices, and healthcare companies across China and the United States. The firm was founded by a team that previously worked together at one of China's leading venture capital firms.

    40% of their portfolio is in Biotech & Life Sciences. Deal activity increased 300% year-over-year (4 deals in the last 12 months). Their most common stage is series-a (48% of deals). Average disclosed round size is $48.8M (across 23 rounds with reported amounts).

    Find people at Sherpa Healthcare Partners on Goldilocks AI

    Portfolio

    23

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    5

    Team

    XO

    Xiangyu Ouyang

    Managing Partner

    RW

    Raymond W. Cohen

    Venture Partner

    YS

    Yina Shi

    Partner

    Z(

    Zhenyu (Luke) Zhang

    Partner

    CC

    Changzu Cai

    Director

    YZ

    Yinxiao Zhu

    PE Investment Financial Analyst

    XD

    Xuan Deng

    Healthcare Venture Investor

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    25 investments
    CompanyRoundAmountDate
    Avisi Technologies logoAvisi TechnologiesSeries A$10.7MFeb 2026
    AAvisiSeries A$10.7MFeb 2026
    Spiro Medical logoSpiro MedicalSeries A$67MJan 2026
    AAvisiSeed$10.7MJan 2026
    Link Cell Therapies logoLink Cell TherapiesSeries A$60MDec 2025
    AArchimedes Vascular, Inc.Series A$2.2MJun 2025
    Brise Pharmaceuticals logoBrise PharmaceuticalsSeries A$20MApr 2024
    ZZWI Therapeutics, Inc.Series A$10MJan 2024
    Grit Bio logoGrit BioSeries B$60MSep 2023
    CChanging BiotechSeries A$22MJul 2022
    ClinChoice logoClinChoiceSeries E$150MJul 2022
    Cataya logoCatayaSeries A$16MJul 2022
    TTherorna Inc.Series A$42MJun 2022
    FFuse Biotherapeutics, IncSeed$9.5MNov 2021
    FFuse BiotherapeuticsSeed$9.5MNov 2021
    Alebund logoAlebundSeries B$54.5MSep 2021
    Bota Bio logoBota BioSeries B$100MJul 2021
    Bota logoBotaUnknown$100MJul 2021
    Edigene logoEdigeneSeries B—Apr 2021
    VVisenSeries B—Jan 2021
    BBota BiosciencesSeries B$100MJan 2021
    BBota BiosciencesSeries A$15MJan 2020
    Appia Bio logoAppia BioSeries A$52M—
    Singleron logoSingleronSeries B$100M—
    Singleron Biotechnologies logoSingleron BiotechnologiesSeries B$100M—

    Top Co-Investors

    Source Code Capital5 shared
    Accanto Partners3 shared
    Good Growth Capital3 shared
    Golden Seeds3 shared
    5Y Capital3 shared
    LAV2 shared
    BioTrack Capital2 shared
    Bits x Bites2 shared
    Viva BioInnovator2 shared
    Loyal Valley Capital2 shared
    ARCH Venture Partners2 shared
    CDH Investments2 shared
    Lake Bleu Capital2 shared
    Sequoia China2 shared
    Matrix Partners China2 shared
    Decent Capital1 shared
    LIAN Group1 shared
    MPC1 shared
    Matrix Partners1 shared
    Icon Ventures1 shared

    Last updated: 8 September 2026